Sleeping beauty mouse models identify candidate genes involved in gliomagenesis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Vyazunova, Irina ^a   Maklakova, Vilena I ^a   Berman, Samuel ^b   De, Ishani ^a   Steffen, Megan D ^a   Hong, Won ^a   Lincoln, Hayley ^a   Morrissy, A Sorana ^c   Taylor, Michael D ^c   Akagi, Keiko ^d   Brennan, Cameron W ^b   Rodriguez, Fausto J ^e   Collier, Lara S ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d OHIO STATE UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PRIMER DNA; TRANSPOSASE; TRANSPOSON;

ABTB2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARID1B GENE; ARTICLE; CARCINOGENESIS; CHD7 GENE; CONTROLLED STUDY; CREBBP GENE; CSF1 GENE; DYRK1A GENE; ELOVL6 GENE; EPIGENETICS; FAF1 GENE; FLI1 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCUS; GLIOBLASTOMA; GLIOMA; GRAMD1C GENE; HEPACAM2 GENE; HUMAN; KPNA4 GENE; LSAMP GENE; MIR101C GENE; MKLN1 GENE; MOLECULAR CLONING; MOUSE; MUTAGENESIS; NAV3 GENE; NFIA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PAG1 GENE; PPP3R1 GENE; PROMOTER REGION; PROTEIN ANALYSIS; RBPJ GENE; RPS6KA5 GENE; SMAD4 GENE; TANC2 GENE; TRANSPOSON; TSG101 GENE; TUMOR SUPPRESSOR GENE; USP9X GENE; ZFP212 GENE; ANIMAL; BRAIN TUMOR; GENETICS; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; DNA PRIMERS; DNA TRANSPOSABLE ELEMENTS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; MICE; POLYMERASE CHAIN REACTION; TRANSPOSASES;

EID: 84912567346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113489     Document Type: Article

References (63)

1. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
2. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
3. Collier LS, Adams DJ, Hackett CS, Bendzick LE, Akagi K, et al. (2009) Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69: 8429-8437.
4. Bender AM, Collier LS, Rodriguez FJ, Tieu C, Larson JD, et al. (2010) Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer research 70: 3557-3565.
5. Foltz CJ, Ullman-Cullere MH (1999) Guidelines for Assessing the Health and Condition of Mice. Lab Animal 28: 5.
6. Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436: 272-276.
7. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226.
8. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, et al. (1997) Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659.
9. Luo G, Santoro IM, McDaniel LD, Nishijima I, Mills M, et al. (2000) Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26: 424-429.
10. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, et al. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87: 4828-4832.
11. Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 10: 13574-13581.
12. Ivics Z, Hackett PB, Plasterk RH, Izsvak Z (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510.
13. Largaespada DA, Collier LS (2008) Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions. Methods Mol Biol 435: 95-108.
14. Wu TD, Nacu S (2010) Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26: 873-881.
15. Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, et al. (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323: 1747-1750.
16. Brett BT, Berquam-Vrieze KE, Nannapaneni K, Huang J, Scheetz TE, et al. (2011) Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PloS one 6: e24668.
17. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, et al. (2002) High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 32: 153-159.
18. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462-477.
19. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14: 1030-1037.
20. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, et al. (2009) Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer cell 15: 45-56.
21. Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, et al. (2002) Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1: 269-277.
22. Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, et al. (2001) hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31: 85-94.
23. Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, et al. (2005) Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8: 119-130.
24. Chow LM, Endersby R, Zhu X, Rankin S, Qu C, et al. (2011) Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer cell 19: 305-316.
25. Ding H, Roncari L, Shannon P, Wu X, Lau N, et al. (2001) Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61: 3826-3836.
26. Bard-Chapeau EA, Nguyen AT, Rust AG, Sayadi A, Lee P, et al. (2014) Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model. Nature genetics 46: 24-32.
27. Koso H, Takeda H, Yew CC, Ward JM, Nariai N, et al. (2012) Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells. Proceedings of the National Academy of Sciences of the United States of America.
28. Suzuki E, Williams S, Sato S, Gilkeson G, Watson DK, et al. (2013) The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice. Immunology 139: 318-327.
29. Hume DA, MacDonald KP (2012) Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119: 1810-1820.
30. Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, et al. (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482: 529-533.
31. Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216: 15-24.
32. Ichimura K, Mungall AJ, Fiegler H, Pearson DM, Dunham I, et al. (2006) Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 25: 1261-1271.
33. Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, et al. (2013) A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes & development 27: 1462-1472.
34. Pozo N, Zahonero C, Fernandez P, Linares JM, Ayuso A, et al. (2013) Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth. The Journal of clinical investigation 123: 2475-2487.
35. Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, et al. (2012) microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-beta signaling in glioblastoma. Cancer discovery 2: 736-749.
36. Ben-David Y, Giddens EB, Letwin K, Bernstein A (1991) Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets- 1. Genes & development 5: 908-918.
37. Klemsz MJ, Maki RA, Papayannopoulou T, Moore J, Hromas R (1993) Characterization of the ets oncogene family member, fli-1. The Journal of biological chemistry 268: 5769-5773.
38. Ho HH, Ivashkiv LB (2010) Downregulation of Friend leukemia virus integration 1 as a feedback mechanism that restrains lipopolysaccharide induction of matrix metalloproteases and interleukin-10 in human macrophages. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research 30: 893-900.
39. Shechter R, Miller O, Yovel G, Rosenzweig N, London A, et al. (2013) Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38: 555-569.
40. Mhawech-Fauceglia P, Herrmann FR, Bshara W, Odunsi K, Terracciano L, et al. (2007) Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. Journal of clinical pathology 60: 694-700.
41. Tagnaouti N, Loebrich S, Heisler F, Pechmann Y, Fehr S, et al. (2007) Neuronal expression of muskelin in the rodent central nervous system. BMC neuroscience 8: 28.
42. Adams JC, Seed B, Lawler J (1998) Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1. The EMBO journal 17: 4964-4974.
43. Heisler FF, Loebrich S, Pechmann Y, Maier N, Zivkovic AR, et al. (2011) Muskelin regulates actin filament- and microtubule-based GABA(A) receptor transport in neurons. Neuron 70: 66-81.
44. Crespo I, Vital AL, Nieto AB, Rebelo O, Tao H, et al. (2011) Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. The Journal of molecular diagnostics: JMD 13: 634-647.
45. Brun M, Glubrecht DD, Baksh S, Godbout R (2013) Calcineurin regulates nuclear factor I dephosphorylation and activity in malignant glioma cell lines. The Journal of biological chemistry 288: 24104-24115.
46. Matsuzaka T, Shimano H (2009) Elovl6: a new player in fatty acid metabolism and insulin sensitivity. Journal of molecular medicine 87: 379-384.
47. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, et al. (2007) Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nature medicine 13: 1193-1202.
48. Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, et al. (2010) Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics 11: 132.
49. Gui Y, Guo G, Huang Y, Hu X, Tang A, et al. (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nature genetics 43: 875-878.
50. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476: 298-303.
51. Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, et al. (2011) Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118: 3080-3087.
52. Mullighan CG, Zhang J, Kasper LH, Lerach S, Payne-Turner D, et al. (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471: 235-239.
53. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471: 189-195.
54. Chung YR, Schatoff E, Abdel-Wahab O (2012) Epigenetic alterations in hematopoietic malignancies. International journal of hematology 96: 413-427.
55. Peifer M, Fernandez-Cuesta L, Sos ML, George J, Seidel D, et al. (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature genetics 44: 1104-1110.
56. Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, et al. (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488: 43-48.
57. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, et al. (2012) Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proceedings of the National Academy of Sciences of the United States of America 109: 3879-3884.
58. Okosun J, Bodor C, Wang J, Araf S, Yang CY, et al. (2013) Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature genetics.
59. Parry M, Rose-Zerilli MJ, Gibson J, Ennis S, Walewska R, et al. (2013) Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PloS one 8: e83244.
60. Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, et al. (2013) The mutational landscape of adenoid cystic carcinoma. Nature genetics 45: 791-798.
61. Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, et al. (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121: 1604-1611.
62. Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, et al. (2014) Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 46: 1097-1102.
63. Song Y, Li L, Ou Y, Gao Z, Li E, et al. (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509: 91-95.